| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |